Cleared Traditional

K250410 - GORE Tri-Lobe Balloon Catheter

K250410 is the FDA 510(k) clearance for GORE Tri-Lobe Balloon Catheter by W.L. Gore & Associates, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 109-day FDA review.

K250410 · W.L. Gore & Associates, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
109d
Days
Class 2
Risk

K250410 is an FDA 510(k) clearance for the GORE® Tri-Lobe Balloon Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by W.L. Gore & Associates, Inc. (Flagstaff, US). The FDA issued a Cleared decision on June 2, 2025 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all W.L. Gore & Associates, Inc. devices

Submission Details

510(k) Number K250410 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2025
Decision Date June 02, 2025
Days to Decision 109 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 125d · This submission: 109d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K250410.
SAT CenterFlow Molding Balloon Catheter (IN20-00313)
K243184 · Strait Access Technologies Holdings · Jun 2025
FlexiGo 3D Delivery Catheter
K250492 · CenterPoint Systems, LLC · Jun 2025
Dorado™ PTA Balloon Dilatation Catheter
K250219 · Bard Peripheral Vascular, Inc. · Jun 2025
Shockwave CS Guide Catheter
K243757 · Shockwave Medical, Inc. · May 2025
APRO 45 Catheter
K251014 · Alembic, LLC · May 2025
APRO 55 Intermediate Catheter
K250962 · Alembic, LLC · Apr 2025